Details of the Drug Reposition

General Information of This Drug (ID: DMB19L8)

• Drug Name: Trihexyphenidyl (DMB19L8)
• Synonyms: trihexyphenidyl; Benzhexol; Triphenidyl; Trihexyphenidyle; Parkinane retard; Benzhexolum; 144-11-6; Trihexyphenidylum; Sedrena (free base); Trihexifenidilo; Trihexyphenidyle [INN-French]; Trihexifenidilo [INN-Spanish]; Trihexyphenidylum [INN-Latin]; Artane; Trihexylphenizyl; Trihexylphenidyl; Trihexylphenidyle; Trihexyphenidyl [INN:BAN]; Trihexylphenedyl; HSDB 3196; EINECS 205-614-4; NSC 12268; 1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-; 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol; BRN 0088959; Benzhexol; Trihexane; Trihexy; Artane Sequels; PMS Trihexyphenidyl; Apo-Trihex; Artane (TN); Trihexyphenidyl (INN); Apo-Trihex (TN); Apo-trihex (TN); SWR-0342SA
• Therapeutic Class: Antiparkinson Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

4 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Postencephalitic Parkinson disease	DIS1TYXP	N.A.	Approved	[1]
Parkinsonian disorder	DISHGY45	N.A.	Approved	[1]
Parkinson disease	DISQVHKL	8A00.0	Approved	[2]
Dystonia	DISJLFGW	8A02	Approved	[2]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Obesity	DIS47Y1K	5B81	Investigative	[3]

References

• [1] Trihexyphenidyl FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7315).
• [3] Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506-21.